RB
Roy Buchanan Citizens Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
30
Avg Return
Past Year
Past Year
81%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
96.7%
Neutral
3.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Market Outperform
Maintained
| $173 |
21%
downside
| 8 | +43% |
0
%
| 3 Oct ‘25 2 months ago |
|
|
|
Market Outperform
Initiated
| $38 |
10%
upside
| 1 | +33% |
0
%
| 24 Sep ‘25 2 months ago |
|
|
|
Market Outperform
Reiterated
| $32 |
195%
upside
| 3 | -0.21% |
0
%
| 22 Aug ‘25 3 months ago |
|
|
|
Market Outperform
Maintained
| $25 |
68%
upside
| 4 | +40% |
0
%
| 12 Aug ‘25 4 months ago |
|
|
|
Market Outperform
Maintained
| $14 |
250%
upside
| 1 | +9% |
0
%
| 17 Jun ‘25 6 months ago |
|
|
|
Market Outperform
Reiterated
| $10 |
100%
upside
| 2 | +17% |
0
%
| 28 May ‘25 6 months ago |
|
|
|
Market Outperform
Maintained
| $2 |
71%
upside
| 4 | +2.2% |
0
%
| 5 May ‘25 7 months ago |
|
|
|
Market Outperform
Reiterated
| $18 |
696%
upside
| 2 | +4.7% |
0
%
| 14 Mar ‘25 9 months ago |
|
|
|
Market Perform
Reiterated
| – | – | 1 | – |
–
| 13 Feb ‘25 10 months ago |
|
|
|
Market Outperform
Reiterated
| $4 |
6%
upside
| 2 | +44% |
0
%
| 11 Feb ‘25 10 months ago |
|
|
|
Market Outperform
Maintained
| $14 |
290%
upside
| 1 | -3.5% |
0
%
| 30 Jan ‘25 10 months ago |
|
|
|
Market Outperform
Reiterated
| $33 |
72%
downside
| 1 | +1,665% |
0
%
| 10 Jan ‘25 11 months ago |
|